BIOMEDICAL CHALLENGES

Biomedical forecasting must incorporate the large amount of uncertainty in getting a product to market, given the large number of trials and approvals necessary. Once approved, the challenge is for constant re-quantification of a global market opportunity, given there changing competitive pressures.

Forecasting within biomedical must quantify and allow competitive intelligence factors to be incorporated. For example, Excel provides an ideal platform for "total addressable market" and associative quantitative analysis.

BIOMEDICAL SOLUTIONS

Forecast vision models allow the capacity to build flexibility within a model, modelling "what if" scenarios for expected future returns given uncertainty. As well as capacity and flexibility to include multiple revenue models - licensing.

Models can be produced with a rapid valuation tool in the event of approaches from "big pharma" and contain inbuilt modelling sensitivity of the model towards pricing, regulatory approvals, costs and potential profitability.

Essential scenario analysis to compare profitability models at various volume thresholds

BIOMEDICAL EXAMPLES

Reviewing and costing of alternative scenarios for an early stage patent protected cancer detection innovation.

Producing a risk adjusted valuation for a medical device prior to FDA final approval.